New customized drug treatment bypasses a single child`s unique mutation within a year of diagnosis
(PHYSorg.com Medicine & Health)

An unprecedented case at Boston Children`s Hospital shows that it`s possible to do something that`s never been done before: identify a patient`s unique mutation, design a customized drug to bypass it, manufacture and test the drug, and obtain permission from the Food and Drug Administration (FDA) to begin treating the patient-all in less than one year.